Oral Delivery of Cannabidiol: Revealing the Formulation and Absorption Challenges

Andrejs Sitovs, Konstantins Logviss (Corresponding Author), Liga Lauberte, Valentyn Mohylyuk (Corresponding Author)

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)

Abstract

Cannabidiol (CBD) is a pharmacologically active, non-psychoactive cannabinoid derived from natural sources. Currently, it is available in prescription oral dosage forms for its anti-epileptic properties. The global market for CBD food supplements and nutraceutical products is showing rapid growth, driven by its wide-ranging pharmacological benefits and good safety profile. Numerous ongoing pharmacological studies aim to uncover new potential indications for CBD. While oral CBD formulations are highly desirable due to the ease of use, their development is challenged by various complexities.
The aim of this review was to investigate published literature and gather useful information aimed at better formulation and the improvement of oral bioavailability in drug delivery of CBD. Our investigation explored the CBD physicochemical properties, its permeation and absorption from the gastrointestinal tract to the systemic circulation, as well as its distribution, metabolism and excretion.
The review has revealed numerous controversies, yet a consensus emerges regarding the low stability and poor oral bioavailability of CBD. Simultaneously, discrepancies remain regarding the CBD apparent permeability, the impact of CBD degradation products on its absorption, the involvement of lymphatic transport, and processes associated with CBD excretion.
It is widely acknowledged that CBD is chemically unstable, especially in acidic environments, and undergoes extensive metabolism, resulting in the formation of pharmacologically active metabolites. Food and lipid-based vehicles enhance the oral bioavailability and reduce absorption variability of CBD-containing products. The formulation challenges for CBD primarily revolve around issues of chemical instability, biological membrane permeability, and presystemic metabolism.
Original languageEnglish
Article number105316
JournalJournal of Drug Delivery Science and Technology
Volume92
DOIs
Publication statusPublished - Feb 2024

Keywords*

  • cannabidiol
  • biopharmaceutical properties
  • oral delivery
  • permeability
  • bioavailability
  • absorption

Field of Science*

  • 3.1 Basic medicine
  • 1.6 Biological sciences
  • 1.4 Chemical sciences

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Oral Delivery of Cannabidiol: Revealing the Formulation and Absorption Challenges'. Together they form a unique fingerprint.
  • Gels (Journal)

    Mohylyuk, V. (Reviewer of journal article)

    7 Feb 2025

    Activity: Publication peer-review and editorial work typesPublication Peer-review

  • Gels (Journal)

    Mohylyuk, V. (Reviewer of journal article)

    20 Jan 202521 Jan 2025

    Activity: Publication peer-review and editorial work typesPublication Peer-review

  • Vadims Šakels

    Mohylyuk, V. (Host) & Šitovs, A. (Host)

    17 Oct 2024

    Activity: Hosting a visitor typesHosting a non-academic visitor

Cite this